share_log

Ionis Pharmaceuticals(IONS.US) Director Sells US$256.28K in Common Stock

moomoo News ·  May 7 17:40

$Ionis Pharmaceuticals (IONS.US)$ Director KLEIN JOSEPH III sold 6,000 shares of common stock on May 3, 2024 at an average price of $42.7128 for a total value of $256.28K.

1715118009002397438.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment